NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘biotechnology’

29 April 2016

UPDATE: The Column Group lands over $535m for third VC fund

dollars cash money dollars capital Biotechnology-focused firm The Column Group has hit the target for its third venture capital fund by collecting over $535m.

11 April 2016

Diversis buys majority stake in Caligor

health healthcare drugs pills medication medical Los Angeles-based private equity firm Diversis Capital has purchased Caligor, a provider of clinical trial supply and logistics services.

19 February 2016

Flagship Ventures backs in-house startup Indigo with $56m

tomato-999110_640 Flagship Ventures has invested $56m in Massachusetts-based biotechnology company Indigo.

20 January 2016

Biotech records strongest year for PE, VC deal volume since 2010, total value dips $

science-1029385_1920 Private equity and venture capital investment in the biotech industry slumped in value in 2015 compared to 2014's highs, but still remained the second-strongest year since 2010.

1 April 2015

BDC Venture, SR One lead $21m Series D for Canadian biotech company

download (3) GlaxoSmithKline's venture capital arm SR One and BDC Venture Capital have co-led a $21m funding round for acute kidney injury specialist Thrasos Therapeutics.

9 March 2015

Biotech VC funding largely targeting new drugs over improving existing treatments $

bio Venture capital funding of biotechnology businesses is heavily focused towards novel drug R&D rather than improving existing treatments, new research suggests.

14 January 2015

New Leaf, Apposite to exit biotech company Convergence to trade partner

four-leaf-clovers-1381213-m The venture capital backers of UK biotechnology company Convergence Pharmaceuticals have reportedly agreed to sell their stakes to Nasdaq-listed Biogen Idec for $675m.

13 January 2015

Qualcomm Ventures forms $100m investment partnership with Novartis

syringe-974378-m Qualcomm Ventures, the venture capital arm of Qualcomm Incorporated, has partnered with Novartis Pharmaceuticals to target early stage companies in the healthcare tech sector.

9 January 2015

Ally Bridge leads $25m Series B round in Hua Medicine

drug-pharma-medical-healthcare Clinical-stage biotechnology company Hua Medicine has closed a $25m Series B financing led by private equity firm Ally Bridge Group.

18 December 2014

Atlas drives $23m Series A round for biotech company

padlock Atlas Ventures has invested the biggest chunk of cash in a $23m funding round for biotechnology company Padlock Therapeutics.

Page 1 of 1012345...10...Last »

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016